Regain of Response to Adalimumab in a Steroid-Dependent Pediatric Patient With Ulcerative Colitis After Undergoing Selective Granulocyte and Monocyte Apheresis

Inflamm Bowel Dis. 2019 Jun 18;25(7):e82-e83. doi: 10.1093/ibd/izy404.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab / therapeutic use*
  • Adolescent
  • Anti-Inflammatory Agents / therapeutic use*
  • Blood Component Removal / methods*
  • Colitis, Ulcerative / therapy*
  • Female
  • Granulocytes
  • Humans
  • Monocytes
  • Remission Induction
  • Steroids / administration & dosage*
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Steroids
  • Adalimumab